Gyaran Peptide
Peptide Biotinylation
Menene Peptide Biotinylation?
Gano abubuwan da suka dace da peptides ko biotinylated peptides (misali. tare da labeled antibodies)Rabuwar biotinylated peptides ko alamar peptides daga waɗanda ba a saka su ba (misali. tare da tethered antibodies)
Alamun na iya zama ƙananan kwayoyin halitta kamar biotin (wanda ke ɗaure da ƙarfi kuma ba a haɗa shi da streptavidin ba) ko gajeriyar jerin peptide. Fitattun misalai na jerin peptide da aka yi amfani da su azaman tags sune alamun epitope kamar alamar Tuta, da HA tag da Myc tag. Alamar da aka haɓaka kwanan nan ita ce alamar ALFA peptide. Domin duk tags, antibodies suna kasuwanci. Duba ƙasa don jeri daban-daban.
Canje-canje na MOL akai-akai yana haɗa peptides masu alamar suna ɗauke da alamun daban-daban. Yawanci ana haɗe alamomin a N-terminus ko C-terminus (ta hanyar cysteine ko lysine), amma bisa manufa za a iya sanya shi a ko'ina. Ana iya raba duk alamun daga peptide ta nau'ikan nau'ikan daban-daban waɗanda ake kira mahaɗa ko ƙwayoyin sarari daban-daban na tsayi daban-daban da polarity.. Idan ana so, linkers za a iya cleavable, misali. ta rage m disulfide bond. Dubi jerin mahaɗan da ke akwai / sarari / PEGylations. Anan akwai wakilcin alamun haɗe-haɗe akai-akai.
Biotinylated da Tagged Peptides
Ana iya amfani da alamun alaƙa kamar biotin don
Gano abubuwan da suka dace da peptides ko biotinylated peptides (misali. tare da labeled antibodies)
· Rabuwar biotinylated peptides ko masu alamar peptides daga waɗanda ba a saka su ba (misali. tare da tethered antibodies)
Alamun na iya zama ƙananan kwayoyin halitta kamar biotin (wanda ke ɗaure da ƙarfi kuma ba a haɗa shi da streptavidin ba) ko gajeriyar jerin peptide. Fitattun misalai na jerin peptide da aka yi amfani da su azaman tags sune alamun epitope kamar alamar Tuta, da HA tag da Myc tag. Alamar da aka haɓaka kwanan nan ita ce alamar ALFA peptide. Domin duk tags, antibodies suna kasuwanci. Duba ƙasa don jeri daban-daban.
Canje-canje na MOL akai-akai yana haɗa peptides masu alamar suna ɗauke da alamun daban-daban. Yawanci ana haɗe alamomin a N-terminus ko C-terminus (ta hanyar cysteine ko lysine), amma bisa manufa za a iya sanya shi a ko'ina. Ana iya raba duk alamun daga peptide ta nau'ikan nau'ikan daban-daban waɗanda ake kira mahaɗa ko ƙwayoyin sarari daban-daban na tsayi daban-daban da polarity.. Idan ana so, linkers za a iya cleavable, misali. ta rage m disulfide bond.
|
Alamar soyayya
|
Jeri
|
Sharhi
|
|---|---|---|
|
Tuta tag |
DYKDDDDK |
Anti flag antibody |
|
HA rana |
YPYDVPDYA |
Anti HA antibody |
|
Yawancin lokaci |
Farashin EQKLISEEDL |
Anti Myc antibody |
|
CPP
|
Jeri
|
Sharhi
|
|---|---|---|
|
Tat (47-57) |
YGRKKRRQRR |
Peptide mai shiga cikin tantanin halitta |
|
Oligo-Arginine |
RRRRRRRRR |
Peptide mai shiga cikin tantanin halitta |
Canje-canjen MOL kuma yana iya samar muku da kewayon alamun amsawa da ke haɗe zuwa peptides. Misalai su ne gabatarwar
- Azides (dauki tare da alkines - danna sunadarai)
- A cikin zanen (dauki tare da thiols, misali. Cys)
- Thiols (dauki tare da maleimides)
- Cys(Pys/Npys) (dauki tare da thiols don samar da disulfides)
Fitattun Bayani
Myeloid takamaiman ɗan adam CD33 mai karɓa ne mai hanawa tare da bambancin aikin ITIM a cikin ɗaukar phosphatases SHP-1 da SHP-2
CD33 wani memba ne na myeloid na musamman na dangin sialic acid mai ɗaure mai karɓa kuma an bayyana shi sosai akan sel progenitor na myeloid amma a ƙananan matakan a cikin sel daban.. Human CD33 yana da ragowar tyrosine guda biyu a cikin yankin cytoplasmic (Y340 da Y358). Lokacin da phosphorylate, waɗannan tyrosines na iya aiki azaman wuraren docking na phosphatases, SHP-1 da/ko SHP-2, yana ba CD33 damar aiki azaman mai karɓar mai hanawa. Anan mun nuna cewa CD33 shine tyrosine phosphorylated a gaban mai hana phosphatase., mamayewa, kuma ya dauki SHP-1 da SHP-2. Nazarin haɗin gwiwa ya nuna cewa Src-family kinase Lck yana da tasiri a phosphorylating Y340, amma ba Y358, yana ba da shawarar cewa waɗannan ragowar na iya aiki a cikin zaɓin ɗaukar nauyin kwayoyin adaftar kuma suna da ayyuka daban-daban.. Ƙarin tallafi don haɗuwa, amma mara amfani, Matsayi na Y340 da Y358 sun fito ne daga nazarin dauri na peptide wanda ya bayyana daukar ma'aikata na SHP-1 da SHP-2 zuwa Y340 amma SHP-2 zuwa Y358 kawai.. Bincike ta amfani da maye gurbi na SHP-1 ya nuna cewa ɗaure Y340 na CD33 ya kasance da farko ga yankin amino Src homology-2 na SHP-1.. An nuna yuwuwar CD33 don yin aiki azaman mai karɓar mai hanawa ta ikonsa na rage-daidaita CD64-induced calcium mobilization in U937. An nuna dogaro da wannan hanawa akan SHP-1 ta hanyar toshe tasirin tsaka-tsakin CD33 tare da mummunan SHP-1.. Wannan sakamakon yana nuna cewa CD33 mai karɓar mai hanawa ne kuma SHP-1 phosphatase yana da muhimmiyar rawa wajen daidaita aikin CD33.. Ƙarin karatu yana da mahimmanci don gano mai karɓa(s) CD33 ya hana a cikin vivo da aikinsa a cikin ci gaban layin myeloid.
Abubuwan Gyaran Peptide masu alaƙa
peptide glycosylation
peptide glycosylation
Peptide glycosylation shine gyare-gyare na covalent wanda zai iya inganta halayen physicochemical na peptides.
Kara karantawapeptide phosphorylation
peptide phosphorylation
Phosphoralation na iya faruwa akan Serine (S, Don zama), Threonine (T, Thr) da kuma Tyrosine (Y, Tyr) sarƙoƙi na gefe ta hanyar haɗin phosphoester
Kara karantawaPeptides masu tasowa
Peptides masu tasowa
Gabatarwar amino acid guda biyu marasa dabi'a wadanda ke dauke da α-methyl, Ƙungiyoyin α-alkenyl yayin haɓakaccen lokaci mai ƙarfi na sarƙoƙi na peptide.
Kara karantawaCyclic Peptide
Cyclic Peptide
Juyin hawan peptide yana haɓaka kwanciyar hankali na peptides (dangane da analogues na layin su) kuma dabara ce ta gama gari a cikin ci gaban peptide.
Kara karantawapeptide gyara
Ƙwarewa mai zurfi a cikin gyaran peptide, samar da hanyoyi masu dacewa da yawa don binciken peptide.